Location History:
- 9934 GM, Delfzijl, NL (2000)
- Delfzijl, NL (2003)
- Groningen, NL (2017 - 2021)
Company Filing History:
2 out of 2 
1 out of 1 
1 out of 8 Years Active: 2000-2021
Title: Anko Cornelus Eissens: Innovator in Drug Delivery Systems
Introduction
Anko Cornelus Eissens, an accomplished inventor based in Groningen, Netherlands, has made significant contributions to the field of drug delivery systems, with a total of five patents to his name. His innovations focus on enhancing the efficacy of drug delivery, particularly in relation to essential amino acids and their therapeutic effects.
Latest Patents
Eissens' latest inventions include a groundbreaking drug delivery system designed for the time-controlled, immediate release of a first active ingredient for oral administration. This innovative system not only ensures optimal drug release timing but also incorporates a dual drug delivery device, which offers a second active ingredient via additional coating. Another notable patent is related to nicotinamide compositions, aimed at addressing deficiencies in essential amino acid absorption. This invention provides methods for treating or preventing symptoms associated with ADHD, ADD, and autism spectrum disorders, utilizing a long-acting formulation of nicotinamide to enhance treatment effectiveness.
Career Highlights
Throughout his career, Eissens has been associated with innovative companies like Eb IP Hybritabs B.V. His work has consistently focused on developing advanced drug delivery mechanisms that improve patient outcomes and address specific medical conditions.
Collaborations
Eissens has collaborated with prominent figures in the field, including Henderik Willem Frijlink and Johannes Martinus Maria Bloemers. These collaborations have fostered innovative approaches to drug formulation and delivery, significantly contributing to advancements in pharmaceuticals.
Conclusion
Anko Cornelus Eissens stands out as a notable inventor whose work in drug delivery systems illustrates the importance of continuous innovation in addressing medical challenges. His contributions not only enhance therapeutic outcomes but also pave the way for future developments in the field of pharmaceuticals.